The Securities and Exchange Commission has announced charges in an alleged insider trading scheme involving tips of nonpublic information about government plans to cut Medicare reimbursement rates, which affected the stock prices of certain publicly traded medical providers or suppliers.
The SEC’s complaint, made public on May 24, alleges that David Blaszczak, a former government employee turned political intelligence consultant, obtained key confidential details about upcoming decisions by the Centers for Medicare and Medicaid Services from his close friend and former colleague at the agency, Christopher Worrall.
According to the SEC’s complaint, Worrall serves as a health insurance specialist in the Center for Medicare and tipped Blaszczak about at least three pending CMS decisions that affected the amount of money that companies receive from Medicare to provide services or products related to cancer treatments or kidney dialysis.
Blaszczak allegedly tipped two analysts at a hedge fund advisory firm that paid him as a consultant. The analysts, Theodore Huber and Jordan Fogel, allegedly used the nonpublic information to recommend that the firm trade in the stocks of four health care companies whose stock prices would likely be affected by the decisions once CMS announced them publicly.
The alleged scheme resulted in more than $3.9 million in illicit profits.
“As alleged in our complaint, a federal employee breached his duty to protect confidential information by tipping a political consultant who then passed along those illegal tips,” Stephanie Avakian, acting director of the Enforcement Division said in a sttaement. “There’s no place on Wall Street or in our government for such blatant misuse of highly confidential information.”
According to the SEC’s complaint, Blaszczak’s firms were paid at least $193,000 throughout a 19-month period by the hedge fund where the analysts worked.
The SEC’s complaint, filed in U.S. District Court for the Southern District of New York, charges Blaszczak, Worrall, Huber, and Fogel with violating Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 as well as Section 17(a) of the Securities Act of 1933.
The complaint seeks disgorgement of ill-gotten gains plus interest, penalties, and permanent injunctions.
In a parallel action, the U.S. Attorney’s Office for the Southern District of New York today announced related criminal charges.